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Basal&Activity& "" 0.076±0.05" 8.55" 0.14" 1.68x104" "" "" 0.055±0.01" 36.13" 0.06" 0.31x104"
Nucleic&Acids& "" "" "" "" "" "" "" "" "" "" ""
"" Circular"DNA" && 0.163±0.03" 11.08" 0.31" 2.77x104" "" && 0.053±0.14" 36.77" 0.06" 0.16x104"
"" dsDNA"(53bp)" 6.8±0.4" 1.57±0.34" 15.9" 2.95" 18.6x104" "" 56.6±3.1" 0.356±0.19" 40.98" 0.38" 0.93x104"
"" ssDNA"(53bp)" >500" 0.620±0.11" 13.73" 1.17" 8.51x104" "" >500" 0.422±0.04" 37.80" 0.34" 0.91x104"
"" dsRNA"(53bp)" 5.8±0.4" 1.02±0.15" 13.44" 1.93" 14.4x104" "" 48.1±2.8" 0.711±0.26" 34.19" 0.76" 2.21x104"
"" ssRNA"(53bp)" >500" 0.512±0.08" 8.72" 0.97" 9.93x104" "" >500" 0.749±0.06" 28.59" 0.80" 2.79x104"
"" ssRNA"(12bp)" "" 0.532±0.05" 11.47" 1.00" 8.74x104" "" "" 0.790±0.1" 32.37" 0.80" 2.60x104"
"" ssRNA"(129bp)" "" 0.646±0.08" 11.54" 1.22" 10.4x104" "" "" 0.756±0.1" 36.48" 0.8" 2.20x104"
Histones& "" "" "" "" "" "" "" "" "" "" ""
"" (H2ALH2B)" >5002" 0.127±0.02" 11.5" 0.24" 2.07x104" "" >500" 0.121±0.04" 34.53" 0.13" 0.37x104"
"" (H3LH4)2" >5002" 0.116±0.01" 10.00" 0.22" 2.19x104" "" >500" 0.135±0.06" 36.65" 0.14" 0.39x104"
Chromatin& "" "" "" "" "" "" "" "" "" "" ""
"" Nuc146" >5001" 0.145±0.01" 10.43" 0.27" 2.61x104" "" >500" 0.083±0.06" 37.39" 0.09" 0.24x104"
"" Nuc165" 2.2±1.51" 1.76±0.22" 15.93" 3.32" 20.9x104" "" 92.8±4.2" 0.204±0.05" 38.78" 0.22" 0.56x104"
"" NLE"Tri" 4.8±2.12" 0.14±0.02" 10.85" 0.26" 2.36x104" "" 381.6±14.2" 0.065±0.04" 38.70" 0.07" 0.20x104"
"" LELTri" 12.7±6.72" 1.70±0.11" 12.83" 3.20" 25.0x104" "" "" 0.206±0.05" 34.15" 0.22" 0.56x104"
ADP9Ribose& "" "" "" "" "" "" "" "" "" "" ""
"" cMAR" "" 0.376±0.03" 10.00" 0.71" 7.08x104" "" "" "" "" "" ""
"" cPaR" "" 0.718±0.06" 9.75" 1.73" 17.7x104" "" "" 0.050±0.04" 31.39" 0.05" 0.17x104"
"" AMLPARPL1"(5')" "" 0.699±0.20" 16.77" 1.32" 7.85x104" "" "" "" "" "" ""
"" AMLPARPL1"(120')" "" 0.600±0.14" 18.63" 1.13" 6.07x10
4" "" "" "" "" "" ""
"" AMLPARPL1"(ON')" "" 0.378±0.11" 13.26" 0.71" 5.38x10
4" "" "" "" "" "" ""
FL9PARP& "" "" "" "" "" "" "" "" "" "" ""
&& PARPL1/PARPL2" 63.0±3.0" 0.248±0.03" 11.69" 0.47" 4.00x104" "" 63.0±3.0" 0.219±0.08" 37.7" 0.2" 0.68x104"














Nucleic&Acids& ## ## ## ## ##
## dsDNA# 6.8±0.4# 0.9# ## 56.6## 0.98#
## ssDNA# >500# ## ## >500# 0.98#
## dsRNA# 5.8±0.4# 0.9# ## #48.1# 0.98#
## ssRNA# >500# ## ## >500# 0.97#
Histones/Chromatin& ## ## ## ##
## (H2ABH2B)# >500# 0.93# ## >500# 0.98#
## NLEBTri# 4.8±2.11# 0.86# ## 381.6±14.2# 0.98#
PARP& ## ## ## ## ##
## UMBPARPB1# ## ## ## 63.0±3.1# 0.95#
## CBPARPB1# ## ## ## 42.0±2.5# 0.93#
## NBPARPB1# ## ## ## BB# BB#
## AMBPARPB1# ## ## ## 32.1±1.8# 0.93#
## UMBPARPB2# ## ## ## BB# BB#












Stoich.& R2& && Stoich.& R2&
Nucleic&Acids& ## ## ## ## ##
## dsDNA# 2#to#1# 0.93# ## 1#to#2# 0.97#
## dsRNA# 1#to#1# 0.93# ## 3#to#2# 0.95#
Chromatin& ## ## ## ## ##
## Nuc165# 1#to#1# 0.95# ## 1#to#1# 0.93#
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Basal#Activity# !! 0.0094! !! !! 0.076±0.05!
Nucleic#Acids# !! !! !! !! !!
!! Circular!DNA! !! 0.188! !! !! 0.163±0.03!
!! dsDNA! 27.8!±!5.6! 0.5411! !! 6.8±0.4! 1.57±0.34!
Histones# !! !! !! !! !!
!! H2A(H2B(! >5002! !! !! >500! 0.127±0.02!
!! (H3(H4)2! >5002! !! !! >500! 0.116±0.01!
Chromatin# !! !! !! !! !!
!! Nuc146! >5001! 0.0823! !! >500! 0.145±0.01!
!! Nuc165! 2.2±1.51! 0.7864*! !! 2.5±0.6! 1.76±0.22!
!! NLE(Tri! 4.8±2.12! !! !! 12.7±0.6! 0.14±0.02!
!! LE(Tri! 12.7±6.72! !! !! !! 1.70±0.11!
## 1!Clark!et!al,!2012.!JBC! 2!Muthurajan!et!al,!2014.!PNAS.! !!

















Basal,Activity, 1.0" 4.8" "" 1.0" 15.4" "" 1.4" 5.4"
Nucleic,Acids, "" "" "" "" "" "" "" ""
"" Circular"DNA" 2.1" 10.4" "" 1.0" 14.9" "" 3.1" 17.3"
"" dsDNA"(53bp)" 20.7" 100.0" "" 6.5" 100.0" "" 4.4" 20.0"
"" ssDNA"(53bp)" 8.2" 39.5" "" 7.7" 118.5" "" 1.5" 9.4"
"" dsRNA"(53bp)" 13.4" 65.0" "" 12.9" 199.7" "" 1.4" 6.5"
"" ssRNA"(53bp)" 6.7" 32.6" "" 13.6" 210.4" "" 0.7" 3.6"
"" ssRNA"(12bp)" 7.0" 33.9" "" 14.4" 221.9" "" 1.5" 3.4"
"" ssRNA"(129bp)" 8.5" 41.1" "" 13.7" 212.4" "" 1.2" 4.7"
Histones, "" "" "" "" "" "" "" ""
"" (H2A?H2B)" 1.5" 8.1" "" 2.2" 34.0" "" 1.0" 5.6"
"" (H3?H4)2" 1.5" 7.4" "" 2.5" 37.9" "" 0.9" 5.6"
Chromatin, "" "" "" "" "" "" "" ""
"" Nuc146" 1.9" 9.2" "" 1.5" 23.3" "" 1.7" 10.9"
"" Nuc165" 23.2" 112.1" "" 3.7" 57.3" "" 8.6" 37.3"
"" NLE"Tri" 1.8" 8.9" "" 1.0" 18.3" "" 2.2" 11.8"
"" LE?Tri" 22.4" 108.3" "" 3.7" 57.9" "" 8.3" 44.6"
ADP:Ribose, "" "" "" "" "" "" "" ""
"" cMAR" 4.9" 23.9" "" "" "" "" "" ""
"" cPAR" 9.4" 45.7" "" 0.9" 14.0" "" 14.4" 104.1"
"" AM?PARP?1"(5')" 9.2" 44.5" "" "" "" "" "" ""
"" AM?PARP?1"(120')" 7.9" 38.2" "" "" "" "" "" ""
"" AM?PARP?1"(ON')" 5.0" 24.1" "" "" "" "" "" ""
FL:PARP, "" "" "" "" "" "" "" ""
,, PARP?1/PARP?2" 3.3" 15.8" "" 4.0" 61.5" "" 1.1" 5.9"
"" *Raw/values/taken/from/Table/1/ "" "" "" "" "" "" "" ""
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Supplementary,Table,6:,Fold,difference,in,PARP:1,and,PARP:2,KD,values,
Binding,Ligand,
Fold,
Difference,
KDapp!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(PARP&2/PARP&1)!
Nucleic,Acids, ,,
## dsDNA#(53bp)# 8.3#
## ssDNA#(53bp)# 1.0#
## dsRNA#(53bp)# 8.3#
## ssRNA#(53bp)# 1.0#
Histones, ##
## (H2A4H2B)# 1.0#
## (H34H4)2# 1.0#
Chromatin, ##
## Nuc146# 1.0#
## Nuc165# 42.2#
## NLE#Tri# 79.5#
,
 
